NCT04663100

Oral Adherence in Hematological Oncology Agents and Impact on Comorbid Therapy Adherence

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (estimated)
• Sponsor: University of Tennessee · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to improve medication, symptom, and disease management of patients with hematological malignancies and multiple chronic conditions (2 or more conditions in addition to cancer) through care coordination between pharmacists working in oncology practices and those working in primary care or community practices (Pharmacists Coordinated care Oncology Model \[PCOM\]). This is a pilot study in which the investigators will examine the association between outcome measures, but the study design and sample size are insufficient to quantify the impact of OAA initiation or OAA adherence on adherence to chronic medications. This pilot study and data analyses are being done in preparation for a larger, controlled study.

Conditions

• Chronic Myeloid Leukemia
• Chronic Lymphocytic Leukemia
• Multiple Myeloma
• Multiple Chronic Conditions

Interventions

Type	Name	Description
OTHER	Patient-reported outcome measure	Participants will complete a patient-reported outcome measure for their oral anticancer agent at two timepoints over 2 months, to assess patient symptoms and adherence to their oral anticancer agent.
OTHER	Comprehensive Medication Review	Following the first patient-reported outcome measure, participants will be contacted by the community pharmacist for a Comprehensive Medication Review (CMR) for their chronic medications. A follow-up CMR will take place after the second patient-reported outcome measure.
OTHER	Pharmacist communication	Throughout the study, the oncology and community pharmacists will communicate about medications through the electronic medical record.

Timeline

• Start date: 2021-02-08
• Primary completion: 2023-12-31
• Completion: 2023-12-31
• First posted: 2020-12-10
• Last updated: 2023-12-04

Locations

1 site across 1 country: United States